Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 276 of 640

Advanced search

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

How Vivek Ramaswamy’s mom manipulated Alzheimer’s data and made her son rich

Oligarch WatchOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style?

finance.yahoo.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Regeneron Targets Cat Allergy Eye Relief With New Phase 3 Antibody Trial

TipRanksOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk’s ziltivekimab misses Phase 3 primary endpoint

drugdiscoverytrends.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Maha FDA suspends licences of Domino's outlets over hygiene

RediffOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Rugonersen's Phase 3 BEACON Trial Doses First Participant

CGTLive®Original source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Global Biotechnology Symposium; Agricultural Biotech for a Better World

Michigan State UniversityOriginal source

🇺🇰Aug 13Regulatorygov.ukTier 1 · Regulatory source

Tetanus: advice for health professionals

Guidance on the management of suspected tetanus cases and on the assessment and management of tetanu...

UK Health Security AgencyOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Type 2 diabetes comorbidity burden rises across major markets

European Pharmaceutical ReviewOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Shelton biotech prepares to restart late-stage cancer trial after funding pause

Hartford Business JournalOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA suspends licences of 4 outlets of leading pizza chain over food safety violations

The Times of IndiaOriginal source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

Post-Hoc: Rewatch the Boston edition of our China Biotech Debate

Endpoints NewsOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Raybow Pharmaceutical

CDP.netOriginal source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide

BioPharma DiveOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Bicara Therapeutics upgraded to Buy on promisin...

PluangOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Domino’s Pizza Licences Suspended by Maharashtra FDA at 4 Outlets Over Hygiene Violations, 3 in Mumbai

latestly.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

New Haven biotech Veradermics ramps up hiring, commercial preparations for hair-loss drug

Hartford Business JournalOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know

finance.yahoo.comOriginal source

🇨🇦Aug 12Researchnews.ubc.caTier 2 · Direct publisher

UBC-developed ‘wood foam’ enters production as Indigenous-led pilot plant opens in Vancouver

University of British ColumbiaOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

FDA chief: Cyclospora ‘effectively removed from the market’

The HillOriginal source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

Deaths reported after treatment with Neurocrine’s approved Prader-Willi drug

biospace.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Legend Biotech stock downgraded at Oppenheimer (LEGN:NASDAQ)

Seeking AlphaOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Opinion: Congress could undermine NC’s biotech boom

The Wake WeeklyOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Belenos’ Keymed licensing deal delivers on Phase II win in rhinosinusitis

Clinical Trials ArenaOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says

marketscreener.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Legend Biotech’s Carvykti Is Turning Growth Into Profit

FinimizeOriginal source

🇺🇸Aug 12CROveristat.comTier 2 · Direct publisher

Scope of Things Podcast: Daphne Smyth on the Chinese Drug Development Market Expansion

VeristatOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Alvelestat Deal Signals Early Manufacturing Push for AATD-LD

PharmTech.comOriginal source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

Psychedelics developer Definium scores more positive data for LSD pill

BioPharma DiveOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Biopharma’s Drawdown Is a Chance to Build Biotech Back Better

Genetic Engineering and Biotechnology NewsOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Make policy based on science, not on RFK’s lifestyle choices

The HillOriginal source

🇺🇸Aug 12CROveristat.comTier 2 · Direct publisher

Life Sciences Today Podcast: Using AI to Reduce Biostatistical Analysis Readouts

VeristatOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (NASDAQ:LEGN) Given New $58.00 Price Target at Royal Bank Of Canada

MarketBeatOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

The Role of Artificial Intelligence In Access

Pharmaceutical CommerceOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (NASDAQ:LEGN) Receives "Market Perform" Rating from Oppenheimer

MarketBeatOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Tissue chips target immunotherapy toxicity prediction without animal models

Drug Target ReviewOriginal source

🌍Aug 12Mediashoulderinnovations.comTier 2 · Direct publisher

Shoulder Innovations announces $4.9M expansion to Byron Center

Shoulder Innovations (ProVoyance + Micro-Robotic)Original source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

InduPro raises a Series B to advance its oncology pipeline

AxiosOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Vykat XR: Seven Deaths Spur Physician Alert for First-Ever PWS Hunger Drug

Tech TimesOriginal source

🇺🇰Aug 12Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 33 report: data to week 32 (data up to 9 August 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Executive Dumps Over 14,000 Shares of Biotech Stock, Valued at $2.3 Million

The Motley FoolOriginal source

🇺🇰Aug 12Regulatorygov.ukTier 1 · Regulatory source

People who inject drugs: HIV and viral hepatitis monitoring

Data tables and commentary for the Unlinked Anonymous Monitoring (UAM) Survey of infections and risk...

UK Health Security AgencyOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical CEO bets on AI for next-gen drugs

Fox BusinessOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

CTT Pharma Corporate Updates

TradingViewOriginal source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

Fresenius pulls one batch of Actemra biosim over glass particle concerns

Fierce PharmaOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Oppenheimer downgrades Legend Biotech stock rating on M&A concerns

Investing.comOriginal source

🌍Aug 12Industrysignanthealth.comTier 1 · Company source

Signant Health Global eCOA Library Surpasses 9,000 Translations

Signant HealthOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Germany: Apax to Acquire €1.5 Billion Pharmaceutical Packaging Businesses from Gerresheimer

leadersleague.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Transcript : BioMarin Pharmaceutical Inc. Presents at Canaccord Genuity's 46th Annual Growth Conference, Aug-12-2026 08

marketscreener.comOriginal source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

After slimming down workforce, Aardvark scraps phase 3 trials as wait for next steps drags on

Fierce BiotechOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Beyond AI And Biotech, Is Robotics India’s Next Healthcare Growth Engine

BW Healthcare WorldOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Biotech Pre-Market Pulse: DRMA, DFTX Jump While SLXN Tumbles

RTTNewsOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $42.00

MarketBeatOriginal source

🇨🇭Aug 12CROpsi-cro.comTier 2 · Direct publisher

PSI CRO recognized as a top place to work globally in 2026

PSI CROOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Why TrumpRx's Real Test Is Access, Not Price

Pharmaceutical CommerceOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

IBD 50 Biotech Scores A Sales Win, Pulling Ahead In Key Rivalry

Investor's Business DailyOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Vance Street Capital-backed Keltec buys AJR Filtration

Filtration and SeparationOriginal source

🇺🇰Aug 12Regulatorygov.ukTier 1 · Regulatory source

Human herpesvirus 8 (HHV-8): referral form

Diagnostic test form (S19) for human herpesvirus 8 (HHV-8).

UK Health Security AgencyOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Zomato under the scanner after Zepto, Food Safety officials visit Bengaluru warehouses: Report

TradingViewOriginal source

🇺🇰Aug 12Regulatorygov.ukTier 1 · Regulatory source

Acute flaccid paralysis and myelitis (AFP/M) in England

Data up to 2025 on acute flaccid paralysis and myelitis in England (AFP/M).

UK Health Security AgencyOriginal source